ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 160 filers reported holding ITEOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 6.56 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,866,197 | +22.5% | 261,753 | +48.2% | 0.00% | – |
| Q2 2023 | $2,339,243 | -69.5% | 176,680 | -68.6% | 0.00% | -100.0% |
| Q1 2023 | $7,665,342 | -53.7% | 563,214 | -33.5% | 0.00% | -50.0% |
| Q4 2022 | $16,539,155 | +4.1% | 846,859 | +1.6% | 0.00% | 0.0% |
| Q3 2022 | $15,885,000 | -26.8% | 833,894 | -20.8% | 0.00% | -33.3% |
| Q2 2022 | $21,697,000 | -16.0% | 1,053,234 | +31.3% | 0.00% | 0.0% |
| Q1 2022 | $25,820,000 | +238.1% | 802,370 | +389.3% | 0.00% | +200.0% |
| Q4 2021 | $7,636,000 | +80.5% | 163,999 | +4.7% | 0.00% | 0.0% |
| Q3 2021 | $4,230,000 | +80.5% | 156,608 | +71.4% | 0.00% | – |
| Q2 2021 | $2,344,000 | +46780.0% | 91,352 | +62469.9% | 0.00% | – |
| Q1 2021 | $5,000 | -98.3% | 146 | -98.3% | 0.00% | – |
| Q4 2020 | $286,000 | +384.7% | 8,453 | +255.9% | 0.00% | – |
| Q3 2020 | $59,000 | – | 2,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |